Piperacillin and Tazobactam Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Piperacillin and Tazobactam Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Jan 20, 2026.

Shortage details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
65219-434-20
Dosage Form
Injection
Presentation
Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)
Initial Posting
Jan 20, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.